BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38146439)

  • 1. Therapeutic effect of ofatumumab in patients with myasthenia gravis: immunoregulation of follicular T helper cells and T helper type 17 cells.
    Li S; Zhang Z; Liu Z
    Front Neurol; 2023; 14():1278250. PubMed ID: 38146439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normalized circulating Tfh and Th17 associates with improvement in myasthenia gravis treated with ofatumumab.
    Song X; He Y; Huo Y; Jiang H; Yu Y; Sun Y; Liu Z; Zhang Z
    Front Immunol; 2024; 15():1280029. PubMed ID: 38415260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATRA alters humoral responses associated with amelioration of EAMG symptoms by balancing Tfh/Tfr helper cell profiles.
    Xie X; Mu L; Yao X; Li N; Sun B; Li Y; Zhan X; Wang X; Kang X; Wang J; Liu Y; Zhang Y; Wang G; Wang D; Liu X; Kong Q; Li H
    Clin Immunol; 2013 Aug; 148(2):162-76. PubMed ID: 23773919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathymic Tfh/B Cells Interaction Leads to Ectopic GCs Formation and Anti-AChR Antibody Production: Central Role in Triggering MG Occurrence.
    Zhang X; Liu S; Chang T; Xu J; Zhang C; Tian F; Sun Y; Song C; Yi W; Lin H; Li Z; Yang K
    Mol Neurobiol; 2016 Jan; 53(1):120-131. PubMed ID: 25407929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus inhibits Th1 and Th17 responses in MuSK-antibody positive myasthenia gravis patients.
    Li Y; Guptill JT; Russo MA; Massey JM; Juel VC; Hobson-Webb LD; Howard JF; Chopra M; Liu W; Yi JS
    Exp Neurol; 2019 Feb; 312():43-50. PubMed ID: 30472069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Follicular Helper T Cells and Inflammatory Cytokines on Myasthenia Gravis.
    Wang L; Zhang Y; Zhu M; Feng J; Han J; Zhu J; Deng H
    Curr Mol Med; 2019; 19(10):739-745. PubMed ID: 31453784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic and Immunoregulatory Effects of Tacrolimus in Patients with Refractory Generalized Myasthenia Gravis.
    Wu H; Wang Z; Xi J; Liu J; Yan C; Song J; Wang L; Jing S; Wang Y; Zhao C
    Eur Neurol; 2020; 83(5):500-507. PubMed ID: 32932253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of memory T cells, follicular T cells and relevant cytokines in the peripheral blood of patients with myasthenia gravis during treatment].
    Ma L; Wu T; He J; Shen X; Yu F
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Mar; 38(3):257-262. PubMed ID: 35365992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequencies of circulating Tfh-Th17 cells in myasthenia gravis patients.
    Yang Y; Zhang M; Ye Y; Ma S; Fan L; Li Z
    Neurol Sci; 2017 Sep; 38(9):1599-1608. PubMed ID: 28578482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unbalanced expression of membrane-bound and soluble inducible costimulator and programmed cell death 1 in patients with myasthenia gravis.
    Yan X; Gu Y; Wang C; Sun S; Wang X; Tian J; Wang M; Ji X; Duan X; Gao H; Fang Q; Dong W; Zhang X; Xue Q
    Clin Immunol; 2019 Oct; 207():68-78. PubMed ID: 31374257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA interference targeting Bcl-6 ameliorates experimental autoimmune myasthenia gravis in mice.
    Xin N; Fu L; Shao Z; Guo M; Zhang X; Zhang Y; Dou C; Zheng S; Shen X; Yao Y; Wang J; Wang J; Cui G; Liu Y; Geng D; Xiao C; Zhang Z; Dong R
    Mol Cell Neurosci; 2014 Jan; 58():85-94. PubMed ID: 24361642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4
    Çebi M; Durmus H; Aysal F; Özkan B; Gül GE; Çakar A; Hocaoglu M; Mercan M; Yentür SP; Tütüncü M; Yayla V; Akan O; Dogan Ö; Parman Y; Saruhan-Direskeneli G
    Front Immunol; 2020; 11():809. PubMed ID: 32508812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of T Follicular Helper Cell-Mediated Humoral Immunity Reponses During Development of Experimental Autoimmune Myasthenia Gravis.
    Cui YZ; Qu SY; Chang LL; Zhao JR; Mu L; Sun B; Li HL; Zhang TS; Wang GY; Kong QF
    Neurosci Bull; 2019 Jun; 35(3):507-518. PubMed ID: 30796753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of soluble forms of follicular helper T-cell membrane molecules in the pathogenesis of myasthenia gravis.
    Akamine H; Uzawa A; Kojima Y; Ozawa Y; Yasuda M; Onishi Y; Kuwabara S
    J Neuroimmunol; 2023 Feb; 375():578014. PubMed ID: 36621075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Skew of Circulating Follicular Helper T Cells Associates With Myasthenia Gravis Severity.
    Ashida S; Ochi H; Hamatani M; Fujii C; Kimura K; Okada Y; Hashi Y; Kawamura K; Ueno H; Takahashi R; Mizuno T; Kondo T
    Neurol Neuroimmunol Neuroinflamm; 2021 Mar; 8(2):. PubMed ID: 33436376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High levels of serum interleukin-6 are associated with disease activity in myasthenia gravis.
    Uzawa A; Akamine H; Kojima Y; Ozawa Y; Yasuda M; Onishi Y; Sawai S; Kawasaki K; Asano H; Ohyama S; Matsushita K; Mori M; Kuwabara S
    J Neuroimmunol; 2021 Sep; 358():577634. PubMed ID: 34174586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of Life in Myasthenia Gravis and Correlation of MG-QOL15 with Other Functional Scales.
    Diez Porras L; Homedes C; Alberti MA; Velez Santamaria V; Casasnovas C
    J Clin Med; 2022 Apr; 11(8):. PubMed ID: 35456281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of Quantitative Myasthenia Gravis and Myasthenia Gravis Activities of Daily Living scales in the MGTX study.
    McPherson T; Aban I; Duda PW; Farzaneh-Far R; Wolfe GI; Kaminski HJ; Cutter G; Lee I;
    Muscle Nerve; 2020 Aug; 62(2):261-266. PubMed ID: 32369631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imbalance in T follicular helper cells producing IL-17 promotes pro-inflammatory responses in MuSK antibody positive myasthenia gravis.
    Li Y; Guptill JT; Russo MA; Howard JF; Massey JM; Juel VC; Hobson-Webb LD; Emmett D; Chopra M; Raja S; Liu W; Yi JS
    J Neuroimmunol; 2020 Aug; 345():577279. PubMed ID: 32497931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile.
    Yang H; Zhang Y; Wu M; Li J; Zhou W; Li G; Li X; Xiao B; Christadoss P
    Inflamm Res; 2010 Mar; 59(3):197-205. PubMed ID: 19768385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.